Please take a moment to read Peter Pitts’ comments about the dangers of repackaging pharmaceuticals in
Massive cross-border diversion in
Nevertheless, repackaging by parallel importers and exporters in
Click here to read the official press release from the European Federation of Pharmaceutical Industries and Associations.
My review of Accenture’s track-and-trace report will appear tomorrow.